Evernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.
Read MoreAddressing obesity in the workplace
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Read MoreResearch: Sleep apnea drives average medical costs up 50% for patients with cardiodiabesity
Researchers have identified sleep apnea as a common comorbidity among patients with cardiodiabesity.
Read MoreEvernorth Continues Work to Reduce Costs and Improve Health With Expanded and Innovative Digital Health Formulary Platform
First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs
Read MoreGLP-1s and digital support: A winning combination
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
Read MoreGLP-1s Medications 101
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreKeeping member health on track: A snapshot of the PBM’s clinical expertise
Express Scripts is helping patients understand and manage their conditions through comprehensive disease management.
Read MoreThree Ways to Optimize a Pharmacy Network
A well-designed pharmacy network strategy offers the right in-network pharmacy coverage to account for population size, geographic area, clinical goals, and utilization patterns.
Read More